# Junta clínica — PT-pseudo_b28f2ad6069e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_b28f2ad6069e",
  "pid": "PT-pseudo_b28f2ad6069e",
  "task": 1,
  "psa": 19.0,
  "age": 64,
  "months": 2,
  "pirads": "4",
  "psad": 0.217,
  "psav": 5.89,
  "psap": 25.8,
  "vol": 87.5,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.7858892,
  "medhx": "Hypertension, Chronic kidney disease, Benign prostatic hyperplasia",
  "meds": "amlodipine, valsartan, metoprolol",
  "notes": "PSA 19 ng/mL. PI-RADS 4. PSAD 0.22. Prostate volume 88 mL. csPCa 0.79.",
  "pmhx": [
    "Hypertension",
    "Chronic kidney disease",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "72 kg",
    "height": "166 cm",
    "bmi": "26.1",
    "bp": "134/72 mmHg",
    "hr": "87 bpm",
    "smoking": "Ex-smoker (27 pack-yr, quit 2018)",
    "last_dental": "6 mo ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "15 Feb 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical assessment requested after earlier biopsy confirmation and latest multiparametric MRI results."
    },
    {
      "s": "History",
      "t": "At 64 years of age, this retired warehouse worker initially came to medical attention due to an incidental PSA elevation noted in late 2022. He is married and currently resides on his own. His medical background encompasses hypertension and chronic kidney disease, managed through amlodipine, valsartan, and metoprolol. Benign prostatic hyperplasia is also part of his clinical picture. He reports minimal lower urinary tract symptoms, scoring a 1 on the IPSS questionnaire. Alcohol consumption remains steady at roughly nine units weekly. A former smoker, he accumulated 27 pack-years before ceasing in 2018. Physical activity is limited to chair-based exercises, though his adult son provides regular support. Aside from urological concerns, he deals with mild bilateral knee osteoarthritis and recently visited audiology for a standard hearing check. He has expressed significant apprehension about invasive interventions, asking for extended time to review potential directions."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and rubbery; mobility: symmetrically enlarged; asymmetry: absent, no palpable nodules detected. General examination remains within normal limits. Blood pressure reads 134/72 mmHg, and heart rate is regular at 87 bpm. Palpation of the abdomen reveals a soft, non-tender surface without evidence of masses or organomegaly."
    }
  ],
  "occupation": "retired warehouse worker",
  "marital": "Married",
  "living": "Lives alone",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Audiology — hearing test"
  ],
  "alcohol": "9 units / week",
  "exercise": "Limited mobility — chair-based exercises only",
  "ipss": "IPSS score: 1/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "OLVG (Amsterdam)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_b28f2ad6069e
Task: 1

Encounter: Urology - outpatient on 15 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 64-year-old male
  - PSA: 19.0 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.217 ng/mL²
  - PSA velocity: 5.89 ng/mL/yr
  - Prior PSA: 25.8 ng/mL
  - Prostate volume: 87.5 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7858892 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Problem list / PMHx: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Current medication: amlodipine, valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 19 ng/mL. PI-RADS 4. PSAD 0.22. Prostate volume 88 mL. csPCa 0.79.

Vitals: weight 72 kg, height 166 cm, BMI 26.1, BP 134/72 mmHg, HR 87 bpm. Smoking: Ex-smoker (27 pack-yr, quit 2018).

Chief complaint: Clinical assessment requested after earlier biopsy confirmation and latest multiparametric MRI results.

History: At 64 years of age, this retired warehouse worker initially came to medical attention due to an incidental PSA elevation noted in late 2022. He is married and currently resides on his own. His medical background encompasses hypertension and chronic kidney disease, managed through amlodipine, valsartan, and metoprolol. Benign prostatic hyperplasia is also part of his clinical picture. He reports minimal lower urinary tract symptoms, scoring a 1 on the IPSS questionnaire. Alcohol consumption remains steady at roughly nine units weekly. A former smoker, he accumulated 27 pack-years before ceasing in 2018. Physical activity is limited to chair-based exercises, though his adult son provides regular support. Aside from urological concerns, he deals with mild bilateral knee osteoarthritis and recently visited audiology for a standard hearing check. He has expressed significant apprehension about invasive interventions, asking for extended time to review potential directions.

Physical examination: DRE — texture: smooth and rubbery; mobility: symmetrically enlarged; asymmetry: absent, no palpable nodules detected. General examination remains within normal limits. Blood pressure reads 134/72 mmHg, and heart rate is regular at 87 bpm. Palpation of the abdomen reveals a soft, non-tender surface without evidence of masses or organomegaly.

Patient info: retired warehouse worker; Married; Lives alone.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 9 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 1/35 (mild LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.56
  uncertainty  +/- 0.08 epistemic (95% band 0.40-0.72); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.49: PI-RADS 4, PSA 6.5, PSAD 0.11, age 64, DRE Normal -> DEFER (uncertain). He wrote: "Need initial ISUP grade and MRI in men on active surveillance."
  2. distance 1.54: PI-RADS 4, PSA 6.8, PSAD 0.2, age 62, DRE Normal -> DEFER (borderline). He wrote: "All depends if the lesion has grown in size since 2024. If stable no biopsy , if increased in size I will do a biopsy."
  3. distance 1.58: PI-RADS 4, PSA 6.7, PSAD 0.2, age 67, DRE Normal -> BIOPSY (borderline). He wrote: "Active surveillance, only one previous biopsy 2 yrs ago. Stable findings (stable PIRADS4, slightly increasing PSA) -> borderline indication for biopsy. As only one previ…"

PRECEDENT: DEFER (weighted vote 0.32 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The guideline addresses the use of MRI to guide biopsy decisions, particularly concerning repeat biopsies or targeted biopsies. "A stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous but it might be excluded in patients with low-risk tumour and a stable low PSA-D < 0.15."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your suggestion of biopsy is not settled because the guideline emphasizes that the decision depends on the documented grade of the prior biopsy and surveillance history, which is what the cohort criterion is focused on. EXPERT-COHORT, the criterion confirms that the visible panel does not determine the decision because the documented grade of the prior biopsy and surveillance history are the deciding factors, which are located in the previous notes.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on the documented grade of the prior biopsy and the surveillance history detailed in the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the MRI report indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What is the trend of the serial PSA values?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy, and is there a surveillance protocol in place?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade (Gleason/ISUP) of the prior biopsy?
  Q2. Is the patient currently on a surveillance protocol with a confirmatory biopsy due?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
COMPARISON: new
LESION: size and zone of the index lesion, as the report words it: "a discrete lesion is visualized, spanning roughly 12 mm at its widest point"

psa_trend
What is the trend of the serial PSA values?: PSA 7.6 (Oct 2022), PSA 7.3 (Dec 2023), PSA 19.0 (Feb 2025)

previous_notes
What is the documented grade of the prior biopsy, and is there a surveillance protocol in place?: The documented grade of the prior biopsy is "ISUP group 2 malignancy", and there is no explicit mention of a surveillance protocol in place.

WHAT I DID NOT OPEN
nothing

WHAT THIS SUPPORTS
FOR sampling this patient now
Prior biopsy result of "ISUP group 2 malignancy" suggests a need for further management.
PSA trend shows a significant rise from 7.6 ng/mL in Oct 2022 to 19.0 ng/mL in Feb 2025.
The MRI report indicates a PI-RADS 4 lesion with specific characteristics.

AGAINST sampling this patient now
nothing

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (clear). Last value 19.00 ng/mL over 3 points spanning 28 months; velocity +4.89 ng/mL per year; doubling time about 21 months.
PROJECTION at 6 months: 66.5 ng/mL, conformal 95% band 19.1-231.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.64
  uncertainty  +/- 0.08 epistemic (95% band 0.47-0.80), of which 0.01 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.56  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.64  ('supports' tier, fusion_nolab; weight 3.0)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.32  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.62 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

Confidence the trace model expects here: clear. Weights it expects: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents retrieved by the registrar—the radiology report, PSA trend, and previous notes—directly address the moderator's questions.

ALIGNMENT WITH THE PANEL
The panel protocol concluded BIOPSY based on a weighted vote of the experts, despite the lack of a documented prior grade in the opened documents. The registrar's findings, specifically the previous notes stating the prior biopsy was "ISUP group 2 malignancy," support the panel's conclusion.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade (Gleason/ISUP) of the prior biopsy? Answered by the previous_notes: "ISUP group 2 malignancy." Q2. Is the patient currently on a surveillance protocol with a confirmatory biopsy due? Answered by the previous_notes: "there is no explicit mention of a surveillance protocol in place."

WHAT CARRIES WEIGHT, AND WHY
The documented prior biopsy grade ("ISUP group 2 malignancy") is the most critical variable as it directly informs the guideline's requirement regarding further management. The rising PSA trend also supports the need for action.

MY SUGGESTION TO THE CHAIR
Based on the retrieved evidence, which indicates a prior ISUP group 2 malignancy and no current surveillance protocol, the guideline suggests treatment rather than further tissue sampling. I suggest deferring a biopsy and proceeding with treatment planning based on the prior diagnosis.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

64y/o, PSA 19.0, PI-RADS 4, prior biopsy grade unrecorded. Rising PSA and unrecorded prior grade mandate sampling for definitive staging. The lack of prior grade is the deciding factor pushing for biopsy over surveillance.

What carried weight: bx=important, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
